Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 4 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected...
Moderna Shares Jump After Better-Than-Expected Sales
The Wall Street Journal· 4 days agoModerna shares shot up about 7% Thursday after reporting better-than-expected quarterly sales and signaling confidence in a sales pickup later this year....
Moderna ends gene editing alliance with Metagenomi
BioPharma Dive via Yahoo Finance· 4 days agoMetagenomi said the companies’ decision to part ways followed a “strategic prioritization” undertaken by Moderna, which has made several investments in...
Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoModerna Inc (NASDAQ:MRNA) faces a significant decrease in revenue and net income, reflecting a 91%...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 4 days agoCash Position: Ended the quarter with $12.2 billion in cash, cash equivalents, and investments, a...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 4 days agoModerna, Inc. MRNA reported earnings of $3.07 per share in the first quarter of 2024, beating the...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
NBC Philadelphia· 4 days agoModerna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting...
Largest U.S. Pension Sold Verizon, Disney, and Peloton Stock. It Bought Moderna.
Barrons.com· 1 day agoCalpers, as the pension is known, disclosed the stock trades, among others, in a form the pension...
Moderna First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 3 days agoModerna (NASDAQ:MRNA) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91%...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 4 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...